Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
IL-13–programmed airway tuft cells produce PGE2, which promotes CFTR-dependent mucociliary function
Maya E. Kotas, … , Max A. Seibold, Erin D. Gordon
Maya E. Kotas, … , Max A. Seibold, Erin D. Gordon
Published May 24, 2022
Citation Information: JCI Insight. 2022;7(13):e159832. https://doi.org/10.1172/jci.insight.159832.
View: Text | PDF
Research Article Inflammation Pulmonology

IL-13–programmed airway tuft cells produce PGE2, which promotes CFTR-dependent mucociliary function

  • Text
  • PDF
Abstract

Chronic type 2 (T2) inflammatory diseases of the respiratory tract are characterized by mucus overproduction and disordered mucociliary function, which are largely attributed to the effects of IL-13 on common epithelial cell types (mucus secretory and ciliated cells). The role of rare cells in airway T2 inflammation is less clear, though tuft cells have been shown to be critical in the initiation of T2 immunity in the intestine. Using bulk and single-cell RNA sequencing of airway epithelium and mouse modeling, we found that IL-13 expanded and programmed airway tuft cells toward eicosanoid metabolism and that tuft cell deficiency led to a reduction in airway prostaglandin E2 (PGE2) concentration. Allergic airway epithelia bore a signature of PGE2 activation, and PGE2 activation led to cystic fibrosis transmembrane receptor–dependent ion and fluid secretion and accelerated mucociliary transport. These data reveal a role for tuft cells in regulating epithelial mucociliary function in the allergic airway.

Authors

Maya E. Kotas, Camille M. Moore, Jose G. Gurrola II, Steven D. Pletcher, Andrew N. Goldberg, Raquel Alvarez, Sheyla Yamato, Preston E. Bratcher, Ciaran A. Shaughnessy, Pamela L. Zeitlin, Irene H. Zhang, Yingchun Li, Michael T. Montgomery, Keehoon Lee, Emily K. Cope, Richard M. Locksley, Max A. Seibold, Erin D. Gordon

×

Figure 3

IL-13 expands and programs airway tuft cells toward PGE2 production.

Options: View larger image (or click on image) Download as PowerPoint
IL-13 expands and programs airway tuft cells toward PGE2 production.
(A)...
(A) T2 inflammatory mouse model system. (B) Representative sections of mouse nasal epithelium after 1 month of IL-13 overexpression or IgG control. Stars mark dual staining IL-25+ and DCLK1+ tuft cells. Bar indicates 50 μm. (C) Quantification of tuft cells in nasal epithelium in control and systemic IL-13 expression. **P < 0.01 by t test. (D) Subclustering of tuft cells from control or IL-13–overexpressing mouse nasal epithelium. (E) Percentage of tuft cells derived from control or systemic IL-13 conditions in each subcluster in D. (F) Human polyp allergic tuft cell gene score in mouse nasal epithelial tuft cell subclusters. ****P < 0.0001 by linear regression model. (G) Schematic of protocol to measure (H) PGE2 metabolites (PGEMs) in whole tracheal tissue from WT or Pou2f3–/– mice exposed to systemic IL-13 or (I) PGE2 in media from tracheal organoids derived from WT or Pou2f3–/– mice. (H and I) *P < 0.05; ***P < 0.001 by t test. For C, H, and I, line is at mean and bars indicate max/min (range).

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts